Pulmonx (LUNG) Work In Process (2019 - 2025)
Pulmonx's (LUNG) quarterly Work In Process came in at $529000.0 in Q4 2025, up 15.75% year-on-year from $457000.0 in Q4 2024, and down 8.32% on a QoQ basis from $577000.0 in Q3 2025.
Pulmonx (LUNG) Work In Process (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has 7 years of Work In Process data on file, last reported at $529000.0 in Q4 2025.
- On a quarterly basis, Work In Process rose 15.75% year-over-year to $529000.0 in Q4 2025; TTM through Dec 2025 was $529000.0, a 15.75% increase from a year earlier, with the FY2025 full-year figure at $529000.0, up 15.75% from the prior year.
- Work In Process for Q4 2025 stood at $529000.0, down from $577000.0 in the prior quarter.
- Over the last five years, Work In Process for LUNG reached as high as $784000.0 in Q2 2022 and fell as low as $313000.0 in Q1 2021.
- Historically, Work In Process has averaged $514600.0 across 5 years, with a median of $510500.0 in 2021.
- Across the five-year window, Work In Process surged 139.62% in 2022 and tumbled 39.15% in 2024, its largest moves.
- Year by year, Work In Process stood at $518000.0 in 2021, then decreased by 25.48% to $386000.0 in 2022, then advanced by 10.62% to $427000.0 in 2023, then increased by 7.03% to $457000.0 in 2024, then climbed by 15.75% to $529000.0 in 2025.
- Per Business Quant data, the three most recent Work In Process figures were $529000.0 in Q4 2025, $577000.0 in Q3 2025, and $562000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Pulmonx | 49.94 Mn | -19.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 529,000.00 |
| Sep 30, 2025 | 577,000.00 |
| Jun 30, 2025 | 562,000.00 |
| Mar 31, 2025 | 503,000.00 |
| Dec 31, 2024 | 457,000.00 |
| Sep 30, 2024 | 369,000.00 |
| Jun 30, 2024 | 387,000.00 |
| Mar 31, 2024 | 440,000.00 |
| Dec 31, 2023 | 427,000.00 |
| Sep 30, 2023 | 541,000.00 |
| Jun 30, 2023 | 636,000.00 |
| Mar 31, 2023 | 473,000.00 |
| Dec 31, 2022 | 386,000.00 |
| Sep 30, 2022 | 550,000.00 |
| Jun 30, 2022 | 784,000.00 |
| Mar 31, 2022 | 750,000.00 |
| Dec 31, 2021 | 518,000.00 |
| Sep 30, 2021 | 708,000.00 |
| Jun 30, 2021 | 382,000.00 |
| Mar 31, 2021 | 313,000.00 |